Within liver cancer (SMMC-7721) cells, ginsenoside Rg3 potentiates oxaliplatin's anti-cancer properties, curbing liver cancer growth and facilitating cell death through the control of PCNA and Cyclin D1 expression [675]. The gene discussed is PCNA; the disease is liver cancer.